| Primary information |
|---|
| ID | 10332 |
| Uniprot ID | Q8CHK2 |
| Description | Relaxin-3 precursor (Prorelaxin M3) (Insulin-like peptide INSL7)(Insulin-like peptide 7) [Cleaved into- - Relaxin-3 B chain; Relaxin-3 Achain]. |
| Organism | Mus musculus |
| Txonomy | Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;Muroidea; Muridae; Murinae; Mus. |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the insulin family. |
| Tissue Specificity | High expression in the brain localized to the pons/medulla with highest levels in pars ventromedialis of the dorsal tegmental nucleus. Significant expression is also detected in the spleen; thymus; lu |
| Post Translational Modification | NA |
| Function | May play a role in neuropeptide signaling processes. Ligand for LGR7; relaxin-3 receptor-1 and relaxin-3 receptor-2 |
| Length | 141 |
| Molecular Weight | 14926 |
| Name | Relaxin-3 B chain |
| Sequence | RPAPYGVKLCGREFIRAVIFTCGGSRW |
| Sequence map | 27 (25-51) |
| PDB ID | NA |
| Drugpedia | NA |
| Receptor | Q8BGE9;Q7TQP4;Q91ZZ5 |
| Domain | NA |
| Pharmaceutical Use | NA
|